BioBlocks: Genesis Biotechnology Group Acquires BioBlocks
Genesis Biotechnology Group® (GBG) and Contract Research Organization (CRO) arm Genesis Drug Discovery & Development (GD3) announced today that it has acquired... Read MoreThe post Genesis Biotechnology Group Acquires BioBlocks appeared first on citybiz.
Read full article »
BioBlocks provides medicinal chemistry services and products to pharmaceutical customers for drug discovery programs.
Read more